Review
Oncology
Andrew Hartley, Imran Ahmad
Summary: PPAR gamma plays an important role in prostate cancer progression and its splice variants may have different effects. While it is a potential target for therapy, the clinical use of drugs targeting PPAR gamma is limited by their associated side effects.
BRITISH JOURNAL OF CANCER
(2023)
Review
Biochemistry & Molecular Biology
Demitria M. Vasilatis, Christopher A. Lucchesi, Paramita M. Ghosh
Summary: Dogs naturally develop prostate cancer similar to aggressive forms found in humans. Prostate cancer samples in dogs often lack androgen receptor (AR), which can enhance our understanding of AR-indifferent prostate cancer in humans. This review highlights the molecular similarities between dog and human prostate cancer variants, suggesting the potential use of dogs as pre-clinical animal models for developing new therapies and diagnostics that can benefit both species.
Editorial Material
Cell Biology
Li Xin
Summary: EZH2 has been shown to promote the development of castration-resistant prostate cancer (CRPC) by interacting with the androgen receptor (AR) to reprogram its transcriptional activity, facilitating the transition of CRPC into a lineage infidelity state.
NATURE CELL BIOLOGY
(2021)
Review
Biochemistry & Molecular Biology
Haozhe Zhang, Yi Zhou, Zengzhen Xing, Rajiv Kumar Sah, Junqi Hu, Hailiang Hu
Summary: This review discusses the close relationship between the evolution of prostate cancer and androgen levels and the status of the androgen receptor. It also explores how alterations in androgen metabolism contribute to the resistance to anti-androgen therapy.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Review
Biochemistry & Molecular Biology
Margherita Corti, Stefano Lorenzetti, Alessandro Ubaldi, Romano Zilli, Daniele Marcoccia
Summary: The role of endocrine disruptors in the human prostate gland is overlooked, but they can influence the homeostasis and diseases of the prostate, including prostate cancer.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Review
Biochemistry & Molecular Biology
Tae Jin Kim, Young Hwa Lee, Kyo Chul Koo
Summary: The androgen receptor (AR) plays a crucial role in the development and progression of prostate cancer (PCa), and treatment for hormone-sensitive prostate cancer (HSPC) relies heavily on androgen deprivation therapy (ADT). Despite most patients progressing to castration-resistant prostate cancer (CRPC), studies suggest that manipulating alternative molecular pathways can help improve current treatments and develop novel therapies for CRPC management.
Article
Oncology
Xiaolei Shi, Abderrahman Day, Hannah E. Bergom, Sydney Tape, Sylvan C. Baca, Zoi E. Sychev, Gabrianne Larson, Asha Bozicevich, Justin M. Drake, Nicholas Zorko, Jinhua Wang, Charles J. Ryan, Emmanuel S. Antonarakis, Justin Hwang
Summary: The study identifies B7-H3 as an immune checkpoint overexpressed in prostate cancer, particularly in metastatic castration-resistant prostate cancer (mCRPC). Enzalutamide-resistant mCRPC cells show increased expression of B7-H3, and it is associated with resistance signaling pathways. The gene network of B7-H3 is strongly correlated with androgen receptor (AR) and its co-factors, suggesting potential therapeutic targets for mCRPC.
NPJ PRECISION ONCOLOGY
(2022)
Article
Biotechnology & Applied Microbiology
Xi Hong, Liang Mao, Luwei Xu, Qiang Hu, Ruipeng Jia
Summary: PSMA plays a crucial role in prostate cancer, and its knockdown leads to metabolic disorder and abnormal transcription, resulting in inhibition of tumor cell proliferation and metastasis.
Article
Oncology
Zemin Hou, Shengsong Huang, Zhenfei Li
Summary: Androgens are crucial in the development of prostate cancer, and targeting steroidogenesis and the androgen receptor has been effective in delaying disease progression. New generation androgen receptor pathway inhibitors like abiraterone and enzalutamide continue to emphasize the role of the androgen-AR axis, even in cases of resistance. The importance of this axis in managing the disease after resistance to current treatments, particularly in neuroendocrine prostate cancer, remains uncertain.
Article
Oncology
Rafael S. Martinez, Mark J. Salji, Linda Rushworth, Chara Ntala, Giovanny Rodriguez Blanco, Ann Hedley, William Clark, Paul Peixoto, Eric Hervouet, Elodie Renaude, Sonia H. Y. Kung, Laura C. A. Galbraith, Colin Nixon, Sergio Lilla, Gillian M. Mackay, Ladan Fazli, Luke Gaughan, David Sumpton, Martin E. Gleave, Sara Zanivan, Arnaud Blomme, Hing Y. Leung
Summary: This study identified SLFN5 as a novel regulator of the LAT1 amino acid transporter in castration-resistant prostate cancer (CRPC), contributing to mTORC1 activity. High expression of SLFN5 in CRPC tumors was correlated with poor patient outcome, indicating its clinical relevance as a potential target for CRPC treatment.
Editorial Material
Hematology
Karen Keeshan
Summary: The study reveals the mechanistic basis for the development of acute myeloid leukemia (AML) mediated by HoxA9 and TRIB proteins, emphasizing their crucial roles in AML oncogenic activity. Further research is needed to explore the synergistic effect of HoxA9 and TRIB proteins in AML pathogenesis, as well as the impact of TRIB proteins on different AML phenotypes.
Article
Medicine, Research & Experimental
Sue Jin Moon, Byong Chang Jeong, Hwa Jin Kim, Joung Eun Lim, Hye-Jeong Kim, Ghee Young Kwon, Joshua A. Jackman, Jeong Hoon Kim
Summary: The study identified BCT as a potent inhibitor targeting both AR-FL and AR-V7 activities in CRPC, effectively suppressing tumor growth and metastasis. Mechanistically, BCT disrupts the interaction of HSP90 with AR-FL/AR-V7, leading to their degradation and showing promising therapeutic potential against CRPC.
Article
Cell Biology
Tingting Zhou, Shengli Wang, Xiaoyu Song, Wensu Liu, Fang Dong, Yunlong Huo, Renlong Zou, Chunyu Wang, Siyi Zhang, Wei Liu, Ge Sun, Lin Lin, Kai Zeng, Xiang Dong, Qiqiang Guo, Fei Yi, Zhuo Wang, Xiaoman Li, Bo Jiang, Liu Cao, Yue Zhao
Summary: The study reveals the potential function of RNF8 in prostate cancer progression and its correlation with poor prognosis. RNF8 regulates prostate cancer development by altering histone modifications and promoting AR transcriptional activity and recruitment. RNF8 may serve as a potential therapeutic target for endocrine-resistant prostate cancer.
CELL DEATH & DISEASE
(2022)
Article
Oncology
Cheng Qian, Dan Li, Yu Chen
Summary: The ETS family of proteins plays critical roles in prostate cancer, and gene fusion and overexpression of certain members have been linked to the development of this cancer. This review provides an overview of the discovery, classification, and therapeutic targeting of ETS family members in prostate cancer.
Review
Biochemistry & Molecular Biology
Navid Sobhani, Praveen Kumar Neeli, Alberto D'Angelo, Matteo Pittacolo, Marianna Sirico, Ilaria Camilla Galli, Giandomenico Roviello, Gabriella Nesi
Summary: Metastatic prostate cancer is the most common cancer in males with a poor prognosis, and many patients develop the AR-V7 variant. AR-V7 acts as a transcription factor in the nucleus, repressing crucial tumor suppressor genes. Anti-AR-V7 drugs show promise for this subset of patients.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Biochemistry & Molecular Biology
Mugdha Patki, Marcela d'Alincourt Salazar, Robert Trumbly, Manohar Ratnam
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
(2015)
Article
Oncology
Ila Datar, Xiaoliang Qiu, Hong Zhi Ma, Miranda Yeung, Shweta Aras, Ivana de la Serna, Fahd Al-Mulla, Jean Paul Thiery, Robert Trumbly, Xuan Fan, Hongjuan Cui, Kam C. Yeung
Correction
Oncology
Ila Datar, Xiaoliang Qiu, Hong Zhi Ma, Miranda Yeung, Shweta Aras, Ivana de la Serna, Fahd Al-Mulla, Tuan Zea Tan, Jean Paul Thiery, Robert Trumbly, Fan Xuan, Hongjuan Cui, Kam C. Yeung
Article
Biochemistry & Molecular Biology
Huihui Tang, Sungdae Park, Shao-Cong Sun, Robert Trumbly, Gang Ren, Eric Tsung, Kam C. Yeung
Article
Biochemistry & Molecular Biology
Mugdha Patki, Venkatesh Chari, Suneethi Sivakumaran, Mesfin Gonit, Robert Trumbly, Manohar Ratnam
JOURNAL OF BIOLOGICAL CHEMISTRY
(2013)
Article
Endocrinology & Metabolism
Mesfin Gonit, Juan Zhang, Marcela d'Alincourt Salazar, Hongjuan Cui, Aymen Shatnawi, Robert Trumbly, Manohar Ratnam
MOLECULAR ENDOCRINOLOGY
(2011)
Article
Multidisciplinary Sciences
Ila Datar, Jingwei Feng, Xiaoliang Qiu, John Lewandowski, Miranda Yeung, Gang Ren, Shweta Aras, Fahd Al-Mulla, Hongjuan Cui, Robert Trumbly, Sri Krishna Chaitanya Arudra, Luis E. De las Casas, Ivana de la Serna, Milad S. Bitar, Kam C. Yeung
Article
Biochemistry & Molecular Biology
Patrick G. Needham, Robert J. Trumbly
Article
Biochemistry & Molecular Biology
ZZ Zhang, U Varanasi, P Carrico, RJ Trumbly
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
(2002)
Article
Genetics & Heredity
ZZ Zhang, U Varanasi, RJ Trumbly
Article
Biochemistry & Molecular Biology
JK Davie, RJ Trumbly, SYR Dent
MOLECULAR AND CELLULAR BIOLOGY
(2002)
Article
Biochemistry & Molecular Biology
G Hong, RJ Trumbly, EM Reimann, KK Schlender
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
(2000)
Article
Oncology
Marcela D. Salazar, Maya Ratnam, Mugdha Patki, Ivana Kisovic, Robert Trumbly, Mohamed Iman, Manohar Ratnam
BREAST CANCER RESEARCH
(2011)